12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Company News  |  Deals

Ariadne Genomics, Hadasit deal

Ariadne and Hadasit's BioMarCare Technologies Ltd. subsidiary partnered to co-develop a diagnostic to predict patient response to metastatic colorectal cancer treatment. BioMarCare will develop the diagnostic, while both companies...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >